Latest total liabilities for CLBT: $490M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Cellebrite DI (CLBT) currently reports a total liabilities of $490M as of September 2026. That compares with $390M in the prior-year period — up 26.5% year over year. Use the charts on this page to explore Cellebrite DI's total liabilities history and peer comparisons.
Cellebrite DI's total liabilities increased from $390M to $490M — a 26.5% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Cellebrite DI reported $490M in total liabilities as of September 2026. That compares with $390M in the prior-year period — up 26.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total liabilities of $490M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cellebrite DI, and consider following CLBT for alerts when major investors trade the stock.
Cellebrite DI is classified in the Technology sector. On total liabilities, it currently shows $490M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing CLBT with unrelated industries.